Begin main content

Reports

We found 6820 result(s)

voretigene neparvovec (Luxturna)

Last Updated: March 25, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: voretigene neparvovec
Indications: Vision loss, inherited retinal dystrophy

  • Brand Name: Luxturna
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0643-000
  • Project Status: Pending
  • Submission Type: New

Narcotics, Benzodiazepines, Stimulants, and Gabapentin: Policies, Initiatives, and Practices Across Canada, 2014

Last Updated: October 10, 2014
Result type: Reports
Product Line: Environmental Scans

Executive Summary Introduction In March 2013, the Canadian Centre on Substance Abuse (CCSA) released their report First Do No Harm: Responding to Canada’s Prescription Drug Crisis, which recognizes prescription drug abuse as the nation’s “leading public health concern.” According to the CCSA, the ready availability of these drugs in Canada, “...

  • Project Number: ES0285

Cholinesterase Inhibitors for Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials

Last Updated: September 2, 2005
Result type: Reports

Technology Cholinesterase inhibitors (ChEIs): donepezil, galantamine and rivastigmine. Disease Alzheimer’s disease (AD) is a form of dementia. Its most common symptom is memory loss. People with AD may forget simple words, misplace items and become disoriented regarding time and place. In 1991, approximately 5% of individuals older than 65 ye...

Botulinum Toxin A for upper and lower limb spasticity: A systematic review

Last Updated: February 4, 2005
Result type: Reports

Technology Name Botulinum toxin A (BTX-A) Disease or Condition Spasticity is a symptom that can cause disability in affected patients. It is characterized by increased muscle tone. Because it may interfere with voluntary movements, it can affect the activities of daily living. Spasticity is treated in an effort to decrease muscle tone, allevi...

Economic evaluation of drug eluting stents

Last Updated: February 25, 2005
Result type: Reports

Disease or Condition Patients with coronary artery disease commonly undergo balloon angioplasty to unblock narrowed arteries carrying blood to the heart. However, a frequent consequence of the treatment is re-narrowing (restenosis) of a blood vessel that has been opened. Technology Description Bare metal stents (BMS) were introduced in 1994 t...

Treatment of inoperable advanced non-small-cell lung cancer: regimens with or without taxane

Last Updated: October 8, 2002
Result type: Reports

Target Audience The review will be helpful to oncologists and other health care providers, researchers and health authorities involved in the management of cancer care and/or the development of cancer care guidelines. Technology Name The anticancer drugs paclitaxel (Taxol®) and docetaxel (Taxotere®) belong to the taxane family. Disease/Condi...

Drug eluting stents: an economic evaluation

Last Updated: February 25, 2005
Result type: Reports

Technology Name Drug eluting stents Disease or Condition Patients with coronary artery disease commonly undergo balloon angioplasty to unblock narrowed arteries carrying blood to the heart. However, a frequent consequence of the treatment is re-narrowing (restenosis) of a blood vessel that has been opened. Technology Description Bare metal ...

erenumab (Aimovig)

Last Updated: April 8, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: erenumab
Indications: Migraine

  • Brand Name: Aimovig
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0578-000
  • Project Status: Active
  • Submission Type: New